SOCS3 and inflammatory bowel disease: SOCS3 targets diverse cytokine pathways by binding to receptors and JAKs and curbs signal transmission, moderating inflammation and immune responses in type 1 diabetes, inflammatory bowel disease (IBD), and psoriasis.